The purpose of this multiple-award, cost-reimbursement, IDIQ contract is to acquire biomedical computing research and development services assisting the division of cancer epidemiology and genetics…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91026D00005
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $4,390 obligated
Award facts
- Opportunity
-
- Biomedical Computing Support Services Pre-Solicitation · 75N91024R00009 · Posted Jan 10, 2024
- Combined order value
- $4,390 Current and potential, with all options
- Last date to order 1% complete
- IDV ceiling <1% used
- $147,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute awarded a multiple-award, cost-reimbursement IDIQ to Westat, Inc. with a ceiling of $147 million on September 29, 2026, to acquire biomedical computing research and development services supporting the Division of Cancer Epidemiology and Genetics and NCI through biomedical data modeling, statistical analysis, and software development.
The contract carries no set-aside designation. Work is performed at Westat's location with services supporting NCI's research infrastructure. The originating pre-solicitation, posted January 10, 2024, sought capability statements from small businesses for multiple awards to provide data modeling and acquisition; data analytics including statistical programming and bioinformatics; and tool and software development supporting DCEG. The Statement of Work defined three task areas: contract initiation, biomedical data services, and data analytics and tool development, to be independently performed by the contractor.
The period of performance runs through September 28, 2031. NAICS code for the effort reflects research and development services. The original pre-solicitation anticipated performance spanning September 2025 through September 2035, with the award executing within that window as one of multiple awards under this program.
Description
The purpose of this multiple-award, cost-reimbursement, IDIQ contract is to acquire biomedical computing research and development services assisting the division of cancer epidemiology and genetics (dceg) and NCI by providing biomedical data modeling
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| 75N91026F00001 | National Cancer Institute (NIH) | $4,390 |
Quick answers
Who was awarded contract 75N91026D00005?
75N91026D00005 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 29, 2026.
How much is contract 75N91026D00005 worth?
Orders under 75N91026D00005 have obligated $4,390. 75N91026D00005's own ceiling is $147,000,000.
How many orders have been placed under contract 75N91026D00005?
1 order has been placed under 75N91026D00005, the latest on September 29, 2026.
Who can order from contract 75N91026D00005?
75N91026D00005 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91026D00005 competed?
The extent of competition for 75N91026D00005 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV